Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Garcia, Elaine"'
Autor:
Oliveira ML; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Veloso A; Molecular Pathology Unit, MGH Research Institute, Charlestown, MA, 02129, USA.; MGH Cancer Center, Harvard Medical School, Charlestown, MA, 02129, USA.; Center for Regenerative Medicine, MGH, Boston, MA, 02114, USA.; Harvard Stem Cell Institute, Cambridge, MA, 02139, USA., Garcia EG; Molecular Pathology Unit, MGH Research Institute, Charlestown, MA, 02129, USA.; MGH Cancer Center, Harvard Medical School, Charlestown, MA, 02129, USA.; Center for Regenerative Medicine, MGH, Boston, MA, 02114, USA.; Harvard Stem Cell Institute, Cambridge, MA, 02139, USA., Iyer S; Molecular Pathology Unit, MGH Research Institute, Charlestown, MA, 02129, USA.; MGH Cancer Center, Harvard Medical School, Charlestown, MA, 02129, USA.; Center for Regenerative Medicine, MGH, Boston, MA, 02114, USA.; Harvard Stem Cell Institute, Cambridge, MA, 02139, USA., Pereira C; Smurfit Institute of Genetics, Trinity College Dublin, University of Dublin, Dublin 2, Ireland., Barreto VM; DNA Breaks Laboratory, CEDOC - Chronic Diseases Research Center, NOVA Medical School - Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Lisbon, Portugal., Langenau DM; Molecular Pathology Unit, MGH Research Institute, Charlestown, MA, 02129, USA. dlangenau@mgh.harvard.edu.; MGH Cancer Center, Harvard Medical School, Charlestown, MA, 02129, USA. dlangenau@mgh.harvard.edu.; Center for Regenerative Medicine, MGH, Boston, MA, 02114, USA. dlangenau@mgh.harvard.edu.; Harvard Stem Cell Institute, Cambridge, MA, 02139, USA. dlangenau@mgh.harvard.edu., Barata JT; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. joao_barata@medicina.ulisboa.pt.
Publikováno v:
Leukemia [Leukemia] 2022 Jun; Vol. 36 (6), pp. 1533-1540. Date of Electronic Publication: 2022 May 17.
Autor:
Loontiens S; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Vanhauwaert S; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Depestel L; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Dewyn G; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Van Loocke W; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Moore FE; Department of Pathology, Massachusetts General Hospital Research Institute, Boston, MA, 02114, USA.; Center of Cancer Research, Massachusetts General Hospital, Charlestown, MA, 02129, USA.; Harvard Stem Cell Institute, Boston, MA, 02114, USA.; Center of Regenerative Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA., Garcia EG; Department of Pathology, Massachusetts General Hospital Research Institute, Boston, MA, 02114, USA.; Center of Cancer Research, Massachusetts General Hospital, Charlestown, MA, 02129, USA.; Harvard Stem Cell Institute, Boston, MA, 02114, USA.; Center of Regenerative Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA., Batchelor L; Section of Pediatric Hematology-Oncology, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA., Borga C; Section of Pediatric Hematology-Oncology, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA., Squiban B; Section of Pediatric Hematology-Oncology, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA., Malone-Perez M; Section of Pediatric Hematology-Oncology, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA., Volders PJ; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Olexiouk V; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Van Vlierberghe P; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Langenau DM; Department of Pathology, Massachusetts General Hospital Research Institute, Boston, MA, 02114, USA.; Center of Cancer Research, Massachusetts General Hospital, Charlestown, MA, 02129, USA.; Harvard Stem Cell Institute, Boston, MA, 02114, USA.; Center of Regenerative Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA., Frazer JK; Section of Pediatric Hematology-Oncology, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA., Durinck K; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium. Kaat.durinck@ugent.be.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium. Kaat.durinck@ugent.be., Speleman F; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Publikováno v:
Leukemia [Leukemia] 2020 Dec; Vol. 34 (12), pp. 3398-3403. Date of Electronic Publication: 2020 Jun 26.
Autor:
Garcia EG; Department of Pathology, Massachusetts General Hospital Research Institute, Boston, MA, 02114, USA.; Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, 02129, USA.; Harvard Stem Cell Institute, Boston, MA, 02114, USA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA., Iyer S; Department of Pathology, Massachusetts General Hospital Research Institute, Boston, MA, 02114, USA.; Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, 02129, USA.; Harvard Stem Cell Institute, Boston, MA, 02114, USA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA., Garcia SP; Department of Pathology, Massachusetts General Hospital Research Institute, Boston, MA, 02114, USA.; Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, 02129, USA.; Harvard Stem Cell Institute, Boston, MA, 02114, USA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA., Loontiens S; Cancer Research Institute Ghent (CRIG) and Center for Medical Genetics, Ghent University, Ghent, Belgium., Sadreyev RI; Department of Pathology, Massachusetts General Hospital Research Institute, Boston, MA, 02114, USA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA., Speleman F; Cancer Research Institute Ghent (CRIG) and Center for Medical Genetics, Ghent University, Ghent, Belgium., Langenau DM; Department of Pathology, Massachusetts General Hospital Research Institute, Boston, MA, 02114, USA. dlangenau@mgh.harvard.edu.; Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, 02129, USA. dlangenau@mgh.harvard.edu.; Harvard Stem Cell Institute, Boston, MA, 02114, USA. dlangenau@mgh.harvard.edu.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA. dlangenau@mgh.harvard.edu.
Publikováno v:
Leukemia [Leukemia] 2018 Aug; Vol. 32 (8), pp. 1860-1865. Date of Electronic Publication: 2018 Apr 18.